• OPEN AN ACCOUNT
Indian Indices
Sensex
72,472.33 879.09
( 1.23%)
Global Indices
Nasdaq
51,671.07 418.43
(0.82%)
Dow Jones
7,831.57 45.21
(0.58%)
Hang Seng
69,084.74 42.63
(0.06%)
Nikkei 225
10,559.70 118.10
(1.13%)
Forex
USD-INR
96.78 0.11
(0.12%)
EUR-INR
108.39 0.07
(0.07%)
GBP-INR
127.86 0.00
(0.00%)
JPY-INR
0.61 0.00
(0.21%)

EQUITY - MARKET SCREENER

Tata Consumer Products Ltd
Industry :  Tea
BSE Code
ISIN Demat
Book Value()
500800
INE192A01025
179.9020553
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
TATACONSUM
57.24
94327.85
EPS(TTM)
Face Value()
Div & Yield %
16.65
1
1.05
 

Beryl Drugs standalone net profit rises 273.33% in the March 2026 quarter
May 29,2026
Net profit of Beryl Drugs rose 273.33% to Rs 0.56 crore in the quarter ended March 2026 as against Rs 0.15 crore during the previous quarter ended March 2025. Sales rose 29.22% to Rs 5.13 crore in the quarter ended March 2026 as against Rs 3.97 crore during the previous quarter ended March 2025.

For the full year,net profit declined 27.59% to Rs 0.42 crore in the year ended March 2026 as against Rs 0.58 crore during the previous year ended March 2025. Sales declined 11.02% to Rs 18.82 crore in the year ended March 2026 as against Rs 21.15 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales5.133.97 29 18.8221.15 -11
OPM %25.9312.59 -12.8112.53 -
PBDT1.260.42 200 2.072.12 -2
PBT0.860.10 760 0.580.87 -33
NP0.560.15 273 0.420.58 -28